Lucie Bouquet

Medicine · Health Sciences

7h-index300citations17works0.82yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(11), Virus-based gene therapy research(7), Viral Infectious Diseases and Gene Expression in Insects(6), Immunotherapy and Immune Responses(5), SARS-CoV-2 and COVID-19 Research(4)

Publications17 total

Abstract 4260: ADV-101: a novel ADC targeting IL-1RAP, leveraging tumor cell and the tumor microenvironment vulnerabilities for enhanced anti-tumor efficacy
Cancer Research·2025
Correction: RapaCaspase-9-based suicide gene applied to the safety of IL-1RAP CAR-T cells
Gene Therapy·2024· 1 citedOpen Access
Abstract 6322: CCTx-001 CAR T-cells targeting the AML specific antigen IL-1RAP show robust pre-clinical anti-tumor efficacy
Cancer Research·2024
Abstract 2360: ADV101, a first-in-class IL-1RAP ADC demonstrates significant anti-tumor activity in solid tumor models
Cancer Research·2024· 1 cited
Development of a New Off-the-Shelf Plasmacytoid Dendritic Cell–Based Approach for the Expansion and Characterization of SARS-CoV-2–Specific T Cells
The Journal of Immunology·2024· 2 citedOpen Access
RapaCaspase-9-based suicide gene applied to the safety of IL-1RAP CAR-T cells
Gene Therapy·2023· 34 citedOpen Access
CAR-T cells targeting IL-1RAP produced in a closed semiautomatic system are ready for the first phase I clinical investigation in humans
Current Research in Translational Medicine·2023· 15 citedOpen Access
Development of a cellular and gene immunotherapy approach based on therapeutic targeting of the SARS-CoV-2 virus by T cells expressing a secure transgenic TCR
theses.fr (ABES)·2022Open Access
Coated recombinant target protein helps explore IL-1RAP CAR T-cell functionality in vitro
Immunologic Research·2022· 7 citedOpen Access
Rapacaspase-9-based Suicide Gene Applied to the Safety of Il-1rap Car-t Cells
Research Square (Research Square)·2022Open Access
Chimeric antigen receptor T-cells targeting IL-1RAP: a promising new cellular immunotherapy to treat acute myeloid leukemia
Journal for ImmunoTherapy of Cancer·2022· 37 citedOpen Access
Production préclinique de CART cells IL-1RAP “GMP-like” en vue d’un essai Clinique de phase Ib.–Expérience bisontine
Transfusion Clinique et Biologique·2021
P-149: Immunogenicity of SARS-CoV-2 vaccine in patients with multiple myeloma
Clinical Lymphoma Myeloma & Leukemia·2021· 1 citedOpen Access
Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies
Blood Cancer Journal·2021· 139 citedOpen Access
Droplet digital PCR allows vector copy number assessment and monitoring of experimental CAR T cells in murine xenograft models or approved CD19 CAR T cell-treated patients
Journal of Translational Medicine·2021· 31 citedOpen Access
Overcoming target epitope masking resistance that can occur on low-antigen-expresser AML blasts after IL-1RAP chimeric antigen receptor T cell therapy using the inducible caspase 9 suicide gene safety switch
Cancer Gene Therapy·2021· 32 citedOpen Access
IL-1RAP, un candidat pour l’immunothérapie par <i>CAR T-cells</i>
médecine/sciences·2019Open Access

Frequent Co-authors

Marina Deschamps(14), Christophe Ferrand(13), Walid Warda(10), Mathieu Neto Da Rocha(10), Clémentine Nicod(10), Rafik Haderbache(10), Rim Trad(9), Delphine Genin(6), Mélanie Guiot(5), Xavier Roussel(4), Richard C.A. Sainson(3), Edouard De Dreuzy(3), Erik Rutjens(3), Jens Hasskarl(3), Florent Malard(2), Joël Gozlan(2), Djeneba Fofana(2), Zoé Van de Wyngaert(2), Souhila Ikhlef(2), Laurence Morand‐Joubert(2)